{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:08:30Z","timestamp":1788988110963,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008459","name":"University of Calgary","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008459","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000261","name":"MS Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012866","name":"Cumming School of Medicine, University of Calgary","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012866","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.neurot.2026.e00943","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T12:55:06Z","timestamp":1781268906000},"page":"e00943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Myelin debris uptake by macrophages and microglia: Resolution of foam cells with a series of novel cyclodextrins"],"prefix":"10.1016","volume":"23","author":[{"given":"Emily C.","family":"Wuerch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charbel S.","family":"Baaklini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene T.","family":"M\u00f8rch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"D'Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Chun","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Wee","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2026.e00943_bib1","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00401-020-02129-7","article-title":"Niacin-mediated rejuvenation of macrophage\/microglia enhances remyelination of the aging central nervous system","volume":"139","author":"Rawji","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurot.2026.e00943_bib2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00401-020-02193-z","article-title":"TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis","volume":"140","author":"Cignarella","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurot.2026.e00943_bib3","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-018-0628-8","article-title":"The physiology of foamy phagocytes in multiple sclerosis","volume":"6","author":"Grajchen","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.neurot.2026.e00943_bib4","doi-asserted-by":"crossref","DOI":"10.1186\/2051-5960-1-43","article-title":"Myelin alters the inflammatory phenotype of macrophages by activating PPARs","volume":"1","author":"Bogie","year":"2013","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.neurot.2026.e00943_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044998","article-title":"Myelin-derived lipids modulate macrophage activity by liver X receptor activation","volume":"7","author":"Bogie","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2026.e00943_bib6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/brain\/awh707","article-title":"Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis","volume":"129","author":"Boven","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neurot.2026.e00943_bib7","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-8-85","article-title":"Myelin-phagocytosing macrophages modulate autoreactive T cell proliferation","volume":"8","author":"Bogie","year":"2011","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neurot.2026.e00943_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1189\/jlb.1209813","article-title":"Myelin ingestion alters macrophage antigen-presenting function in vitro and in vivo","volume":"90","author":"van Zwam","year":"2011","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.neurot.2026.e00943_bib9","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191660","article-title":"Stearoyl-CoA desaturase-1 impairs the reparative properties of macrophages and microglia in the brain","volume":"217","author":"Bogie","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.neurot.2026.e00943_bib10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","article-title":"A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis","volume":"597","author":"Absinta","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.neurot.2026.e00943_bib11","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","article-title":"Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain","volume":"23","author":"Marschallinger","year":"2020","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neurot.2026.e00943_bib12","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neurot.2026.e00943_bib13","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1161\/01.CIR.0000160864.31351.C1","article-title":"Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice","volume":"111","author":"Zhou","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.neurot.2026.e00943_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1083\/jcb.200502078","article-title":"Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor","volume":"171","author":"Devries-Seimon","year":"2005","journal-title":"J Cell Biol"},{"key":"10.1016\/j.neurot.2026.e00943_bib15","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/j.2042-7158.2010.01030.x","article-title":"Pharmaceutical applications of cyclodextrins: basic science and product development","volume":"62","author":"Loftsson","year":"2010","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.neurot.2026.e00943_bib16","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jnc.14895","article-title":"Niemann-pick type C disease: cellular pathology and pharmacotherapy","volume":"153","author":"Wheeler","year":"2020","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurot.2026.e00943_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006951","article-title":"Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression","volume":"4","author":"Davidson","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neurot.2026.e00943_bib18","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1073\/pnas.0810895106","article-title":"Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-\/- mouse","volume":"106","author":"Liu","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurot.2026.e00943_bib19","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1194\/jlr.M700525-JLR200","article-title":"Genetic variations and treatments that affect the lifespan of the NPC1 mouse","volume":"49","author":"Liu","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.neurot.2026.e00943_bib20","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0140-6736(17)31465-4","article-title":"Intrathecal 2-hydroxypropyl-\u03b2-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial","volume":"390","author":"Ory","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.neurot.2026.e00943_bib21","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s40263-019-00642-2","article-title":"Long-Term neuropsychological outcomes from an open-label phase I\/IIa trial of 2-Hydroxypropyl-\u03b2-Cyclodextrins (VTS-270) in Niemann-Pick Disease, type C1","volume":"33","author":"Farmer","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neurot.2026.e00943_bib22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ymgme.2022.10.004","volume":"137","author":"Hastings","year":"2022","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.neurot.2026.e00943_bib23","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41586-022-05439-w","article-title":"APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes","volume":"611","author":"Blanchard","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.neurot.2026.e00943_bib24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1523\/JNEUROSCI.0933-21.2021","article-title":"Repeated administration of 2-Hydroxypropyl-\u03b2-Cyclodextrin (HP\u03b2CD) attenuates the chronic inflammatory response to experimental stroke","volume":"42","author":"Becktel","year":"2022","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurot.2026.e00943_bib25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/mds.28810","article-title":"Parkinson's Disease phenotypes in patient neuronal cultures and brain organoids improved by 2-Hydroxypropyl-\u03b2-Cyclodextrin treatment","volume":"37","author":"Jarazo","year":"2022","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurot.2026.e00943_bib26","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.2174\/1381612823666171019164220","article-title":"2-Hydroxypropyl-\u03b2-cyclodextrins and the blood-brain barrier: considerations for Niemann-Pick Disease type C1","volume":"23","author":"Calias","year":"2017","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.neurot.2026.e00943_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2023.133723","article-title":"Synthesis of \u03b2-cyclodextrin-based per-6-phosphoramidates","volume":"149","author":"Che","year":"2023","journal-title":"Tetrahedron"},{"issue":"662","key":"10.1016\/j.neurot.2026.e00943_bib28","article-title":"Cyclodextrin-based polyanionic and non-ionic dendrimers","volume":"10","author":"Ling","year":"2020","journal-title":"US Patent"},{"key":"10.1016\/j.neurot.2026.e00943_bib29","series-title":"Multifunctional polyanionic cyclodextrin dendrimers","author":"Ling","year":"2018"},{"key":"10.1016\/j.neurot.2026.e00943_bib30","doi-asserted-by":"crossref","DOI":"10.14806\/ej.17.1.200","article-title":"CUTADAPT removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet J"},{"key":"10.1016\/j.neurot.2026.e00943_bib31","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.neurot.2026.e00943_bib32","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.7563.1","article-title":"Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences","volume":"4","author":"Soneson","year":"2015","journal-title":"F1000Res"},{"key":"10.1016\/j.neurot.2026.e00943_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.neurot.2026.e00943_bib34","first-page":"275","article-title":"False discovery rates: a new deal","volume":"18","author":"Stephens","year":"2017","journal-title":"Biostatistics"},{"key":"10.1016\/j.neurot.2026.e00943_bib35","series-title":"EnhancedVolcano: Publication-ready volcano plots with enhanced colouring and labeling","author":"Blighe","year":"2023"},{"key":"10.1016\/j.neurot.2026.e00943_bib36","series-title":"Pheatmap: pretty heatmaps","author":"Kolde","year":"2018"},{"key":"10.1016\/j.neurot.2026.e00943_bib37","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in Ingenuity Pathway Analysis","volume":"30","author":"Kr\u00e4mer","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neurot.2026.e00943_bib38","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1515\/BC.2009.035","article-title":"Central nervous system: cholesterol turnover, brain development and neurodegeneration","volume":"390","author":"Dietschy","year":"2009","journal-title":"Biol Chem"},{"key":"10.1016\/j.neurot.2026.e00943_bib39","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.plipres.2011.06.002","article-title":"Cholesterol metabolism in neurons and astrocytes","volume":"50","author":"Pfrieger","year":"2011","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.neurot.2026.e00943_bib40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41423-021-00827-0","article-title":"Reprogramming cholesterol metabolism in macrophages and its role in host defense against cholesterol-dependent cytolysins","volume":"19","author":"Lee","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.neurot.2026.e00943_bib41","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.it.2018.01.012","article-title":"Lipid droplets as immune modulators in Myeloid cells","volume":"39","author":"den Brok","year":"2018","journal-title":"Trends Immunol"},{"key":"10.1016\/j.neurot.2026.e00943_bib42","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.4049\/jimmunol.1700263","article-title":"New insights into the role of IL-1\u03b2 in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"198","author":"Lin","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.neurot.2026.e00943_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00492","article-title":"Stage-Specific role of interferon-gamma in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"6","author":"Arellano","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.neurot.2026.e00943_bib44","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191390","article-title":"Pro-inflammatory activation following demyelination is required for myelin clearance and oligodendrogenesis","volume":"217","author":"Cunha","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.neurot.2026.e00943_bib45","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.neuron.2022.09.023","article-title":"CNS remyelination and inflammation: from basic mechanisms to therapeutic opportunities","volume":"110","author":"Franklin","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.neurot.2026.e00943_bib46","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1523\/JNEUROSCI.21-18-07046.2001","article-title":"Interleukin-1beta promotes repair of the CNS","volume":"21","author":"Mason","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurot.2026.e00943_bib47","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11224-016-0884-9","article-title":"Cyclodextrin-Lipid complexes: cavity size matters","volume":"28","author":"Szente","year":"2017","journal-title":"Struct Chem"},{"key":"10.1016\/j.neurot.2026.e00943_bib48","article-title":"Myelin lipid metabolism and its role in myelination and myelin maintenance","volume":"4","author":"Barnes-V\u00e9lez","year":"2023","journal-title":"Innovation"},{"key":"10.1016\/j.neurot.2026.e00943_bib49","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210227","article-title":"TREM2-dependent lipid droplet biogenesis in phagocytes is required for remyelination","volume":"218","author":"Gouna","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.neurot.2026.e00943_bib50","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-022-04547-0","article-title":"Perilipin-2 limits remyelination by preventing lipid droplet degradation","volume":"79","author":"Loix","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.neurot.2026.e00943_bib51","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1080\/15548627.2022.2047343","article-title":"Targeting lipophagy in macrophages improves repair in multiple sclerosis","volume":"18","author":"Haidar","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.neurot.2026.e00943_bib52","doi-asserted-by":"crossref","first-page":"9442","DOI":"10.1074\/jbc.M115.636803","article-title":"\u03b2-Cyclodextrin-threaded biocleavable polyrotaxanes ameliorate impaired autophagic flux in Niemann-Pick type C disease","volume":"290","author":"Tamura","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurot.2026.e00943_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010101","article-title":"Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease","volume":"7","author":"Vite","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.neurot.2026.e00943_bib54","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1093\/brain\/awv289","article-title":"Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelination","volume":"138","author":"Natrajan","year":"2015","journal-title":"Brain"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926001133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926001133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:33:42Z","timestamp":1788986022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747926001133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1878747926001133"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00943","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myelin debris uptake by macrophages and microglia: Resolution of foam cells with a series of novel cyclodextrins","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00943","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00943"}}